scholarly journals Comparison of the Aptima HIV-1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 Test for HIV-1 viral load quantification in plasma samples from HIV-1-infected patients

2018 ◽  
Vol 1 (4) ◽  
pp. e31 ◽  
Author(s):  
Serena Longo ◽  
Isabella Bon ◽  
Giuseppina Musumeci ◽  
Alessia Bertoldi ◽  
Vanessa D'Urbano ◽  
...  
Keyword(s):  
Viral Load ◽  
Plasma Samples ◽  
Cobas Taqman ◽  
Viral Load Quantification ◽  
Hiv 1

scholarly journals Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification

2015 ◽  
Vol 31 (4) ◽  
pp. 188-193 ◽  
Author(s):  
Yi-Ching Tung ◽  
Liang-Yin Ke ◽  
Po-Liang Lu ◽  
Kuei-Hsiang Lin ◽  
Su-Chen Lee ◽  
...  
Keyword(s):  
Viral Load ◽  
Cobas Taqman ◽  
Viral Load Quantification ◽  
Hiv 1 ◽  
Roche Cobas

scholarly journals Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay

2010 ◽  
Vol 47 (1) ◽  
pp. 4-7 ◽  
Author(s):  
Mauro Andreotti ◽  
Maria Pirillo ◽  
Giovanni Guidotti ◽  
Susanna Ceffa ◽  
Giovanna Paturzo ◽  
...  
Keyword(s):  
Viral Load ◽  
Dried Blood Spots ◽  
Taqman Assay ◽  
Cobas Taqman ◽  
Blood Spots ◽  
Viral Load Quantification ◽  
Hiv 1 ◽  
Roche Cobas

Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria

2015 ◽  
Vol 13 (4) ◽  
pp. 262-267 ◽  
Author(s):  
Ado Abubakar ◽  
Nicaise Ndembi ◽  
Obinna Ogbanufe ◽  
Auchi Inalegwu ◽  
Simi Wilson ◽  
...  
Keyword(s):  
Viral Load ◽  
Cobas Taqman ◽  
Version 2.0 ◽  
Improved Performance ◽  
Hiv 1

scholarly journals Mechanistic Evaluation of the Pros and Cons of Digital RT-LAMP for HIV-1 Viral Load Quantification on a Microfluidic Device and Improved Efficiency via a Two-Step Digital Protocol

2013 ◽  
Vol 85 (3) ◽  
pp. 1540-1546 ◽  
Author(s):  
Bing Sun ◽  
Feng Shen ◽  
Stephanie E. McCalla ◽  
Jason E. Kreutz ◽  
Mikhail A. Karymov ◽  
...  
Keyword(s):  
Viral Load ◽  
Microfluidic Device ◽  
Pros And Cons ◽  
Viral Load Quantification ◽  
Hiv 1

Comparison of HIV-1 Viral Load between Abbott m2000 and Roche COBAS TaqMan Methods

2010 ◽  
Vol 02 (03) ◽  
Author(s):  
Joseph Nkeze Dong Liang ◽  
Heather Adkins Richard Y. Zhao
Keyword(s):  
Viral Load ◽  
Cobas Taqman ◽  
Hiv 1 ◽  
Roche Cobas

Cerebrospinal Fluid Viral Load Quantification in an HIV-1-Infected Pediatric Group

2007 ◽  
Vol 46 (4) ◽  
pp. 508-509 ◽  
Author(s):  
Cristiane M Rocha ◽  
Daisy M Machado ◽  
Maria Cecilia Sucupira ◽  
Regina C Succi
Keyword(s):  
Cerebrospinal Fluid ◽  
Viral Load ◽  
Viral Load Quantification ◽  
Hiv 1

Inaccurate HIV-1 viral load quantification by three major commercially available methods

AIDS ◽  
1999 ◽  
Vol 13 (6) ◽  
pp. 727 ◽  
Author(s):  
R.B. Oelrichs ◽  
W.B. Dyer ◽  
J.C. Downie ◽  
K. Harvey ◽  
J.S. Sullivan ◽  
...  
Keyword(s):  
Viral Load ◽  
Viral Load Quantification ◽  
Hiv 1

Evaluation of the use of plasma preparation tubes for HIV viral load testing on the COBAS AmpliPrep/COBAS TaqMan HIV-1 version 2.0

2013 ◽  
Vol 187 (2) ◽  
pp. 248-250 ◽  
Author(s):  
Dominique Goedhals ◽  
Lesley E. Scott ◽  
Serena Moretti ◽  
Mark A. Cooper ◽  
Willem J.L. Opperman ◽  
...  
Keyword(s):  
Viral Load ◽  
Load Testing ◽  
Hiv Viral Load ◽  
Cobas Taqman ◽  
Viral Load Testing ◽  
Version 2.0 ◽  
Hiv 1

scholarly journals Kinetics of HIV-1 in cerebrospinal fluid and plasma in cryptococcal meningitis

2012 ◽  
Vol 4 (1) ◽  
pp. 30 ◽  
Author(s):  
Diego M. Cecchini ◽  
Ana M. Cañizal ◽  
Haroldo Rojas ◽  
Alicia Arechavala ◽  
Ricardo Negroni ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Viral Load ◽  
Cryptococcal Meningitis ◽  
Clinical Course ◽  
Plasma Concentrations ◽  
Plasma Samples ◽  
Viral Kinetics ◽  
Opportunistic Disease ◽  
Kinetics Of ◽  
Hiv 1

In order to determine HIV-1 kinetics in cerebrospinal fluid (CSF) and plasma in patients with cryptococcal meningitis (CM), we undertook a prospective collection of paired CSF/plasma samples from antiretroviral therapy- free HIV-infected patients with CM. Samples were obtained at baseline (S1) and at the second (S2) and third (S3) weeks of antifungal therapy. HIV-1 CSF concentrations were significantly lower in both S2 and S3 with respect to S1. Plasma concentrations remained stable. HIV-1 concentrations were higher in plasma than CSF in all cases. Patients who survived the episode of CM (but not those who died) showed a decrease in CSF viral load, what suggests different viral kinetics of HIV-1 in the CSF according to the clinical course of this opportunistic disease.

Sign in / Sign up

Export Citation Format

Share Document